Persimmon PLC - York, England-based housebuilder - To rejoin FTSE 100 index on Tuesday as acquisition of Cheshire, England-based veterinary drug maker Dechra Pharmaceuticals PLC edges closer. Baillie Gifford US Growth Trust PLC will be added to the FTSE 250 index. The Dechra offers values the firm at around GBP4.5 billion. Read More
Dechra Pharmaceuticals PLC - Cheshire, England-based veterinary drug maker - European Commission on Friday clears takeover of Dechra by funds managed by EQT Fund Management Sarl, together with Luxinva SA. As a result, all conditions of the offer relating to antitrust and regulatory approvals have been met. Takeover is expected to complete on January 16, and Dechra shares will be cancelled from trading in London from the market open the next day. The offer values Dechra at 3,875 pence per share, or about GBP4.5 billion in total. Read More
Hargreaves Lansdown PLC - Bristol, England-based wealth management platform - Hires Alison Platt, the current chair of Dechra Pharmaceuticals PLC, to be next its non-executive chair. Platt replaces Deanna Oppenheimer, who will leave the Hargreaves board at its annual general meeting on Friday next week, having been chair for six years. Platt will join the Hargreaves board in early 2024. Until regulatory approval for Platt, Senior Independent Director Penny James will be interim chair. Dechra, a veterinary drugmaker, has agreed to be taken over by EQT, which is a Swedish private equity firm, and Luxinva SA, which is controlled by the sovereign wealth fund of the United Arab Emirates. The GBP4.5 billion deal is expected to be completed by early 2024. Platt also is a non-executive director of grocer Tesco PLC and chair of general insurer Ageas (UK) Ltd. Previously, she led estate agent Countrywide as chief executive officer from 2014 to 2018. Read More
(Alliance News) - Stock prices in London opened mixed on Wednesday, as large caps fell on account of a stronger pound, though the domestically-focused midcap index rose. Read More
(Alliance News) - Stocks in London are expected to open lower on Wednesday, as investors consider the latest dovish remarks from the US Federal Reserve. Read More
(Alliance News) - Dechra Pharmaceuticals PLC on Monday said Director Tony Griffin has stepped down after 12 years in the role, effective immediately. Read More
(Alliance News) - Dechra Pharmaceuticals PLC on Thursday said it swung to an annual loss as it lamented high inflation and cost of sales, despite growth in all pharmaceutical product categories. Read More
(Alliance News) - Stocks in London are called higher on Thursday, following an upbeat trading session in Asia. Read More
(Alliance News) - Stocks in London are set to open higher on Thursday as market focus turns to inflation and whether it is cooling enough to justify a pause in September from the European Central Bank and the US Federal Reserve. Read More
(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 18, after completing its quarterly review. Read More
(Alliance News) - Stock prices in London opened higher on Wednesday, as the mood in European markets continued to improve. Read More
(Alliance News) - Marks & Spencer Group PLC is primed to make a return to London's premier FTSE 100 index, roughly three years after the founding member was booted out, with abrdn PLC once again among those making way. Read More
(Alliance News) - Dechra Pharmaceuticals PLC on Tuesday said that its takeover by EQT AB has passed antitrust hurdles in both Brazil and Austria, but is still awaiting approval in the EU and Australia. Read More
Dechra Pharmaceuticals PLC - veterinary drug maker - Says private equity takeover approved at court and general meeting. Dechra says holders of 99% of scheme shares voted in favour at a court meeting. At a general meeting, 99% also backed it. Dechra in June agreed to a downwardly adjusted takeover by EQT AB, which is a Swedish private equity firm, and Luxinva SA, which is controlled by the sovereign wealth fund of the United Arab Emirates. The offer values Dechra at GBP4.46 billion on a fully-diluted basis and gives an enterprise value of GBP4.88 billion. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More
(Alliance News) - Takeovers involving UK companies declined over the first three months of the year, amid tough economic conditions and political uncertainty, according to provisional official figures. Read More
(Alliance News) - Stocks in London ended higher on Friday as markets digested the latest US employment report, which came in far hotter than expected, and cheered as a bill to raise the US debt ceiling passed the Senate. Read More